Business Wire Frequency Therapeutics, Inc. (Nasdaq: FREQ) today announced business updates and financial results for the second quarter ended June 30, 2023. In July, the Company announced that it entered into a...\n more…
Business Wire Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (KSF) are investigating the proposed sale of Frequency Therapeutics, Inc. (NasdaqGS: FREQ) to Korro Bio, Inc. Under the terms of the proposed transaction, pre-merger Frequency...\n more…
Yahoo! Finance: News Korro Bio Inc and Frequency Therapeutics Inc (NASDAQ: FREQ) announced an all-stock merger transaction. Under the merger agreement's terms, stockholders of Korro Bio will receive newly issued shares of Frequency Therapeutics. Frequency Therapeutics has discontinued developing its remyelination program for Multiple Sclerosis as it explores strategic alternatives for the program.\n more…
Business Wire Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Frequency Therapeutics, Inc. (NASDAQ: FREQ) and Korro Bio, Inc. is fair to Frequency shareholders. Pre-merger Frequency shareholders are expected to own approximately 8% of the combined company. Halper Sadeh...\n more…
TipRanks Financial Blog Frequency Therapeutics (NASDAQ:FREQ) shares are up a massive 63% at the time of writing today after the biotechnology company agreed to merge with Korro Bio in an a...\n more…
InvestorPlace InvestorPlace - Stock Market News, Stock Advice & Trading Tips\nFrequency Therapeutics (FREQ) stock is rocketing higher on Friday with heavy trading following news that it will combine with Korro...\n more…